Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Wave Life Sciences (WVE) Operating Expenses (2016 - 2025)

Historic Operating Expenses for Wave Life Sciences (WVE) over the last 11 years, with Q3 2025 value amounting to $64.0 million.

  • Wave Life Sciences' Operating Expenses rose 1373.07% to $64.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $245.2 million, marking a year-over-year increase of 1921.45%. This contributed to the annual value of $218.7 million for FY2024, which is 2063.09% up from last year.
  • Wave Life Sciences' Operating Expenses amounted to $64.0 million in Q3 2025, which was up 1373.07% from $61.5 million recorded in Q2 2025.
  • Wave Life Sciences' Operating Expenses' 5-year high stood at $64.0 million during Q3 2025, with a 5-year trough of $37.9 million in Q4 2021.
  • For the 5-year period, Wave Life Sciences' Operating Expenses averaged around $48.4 million, with its median value being $44.8 million (2022).
  • As far as peak fluctuations go, Wave Life Sciences' Operating Expenses plummeted by 1972.71% in 2021, and later soared by 2732.2% in 2024.
  • Wave Life Sciences' Operating Expenses (Quarter) stood at $37.9 million in 2021, then increased by 18.29% to $44.8 million in 2022, then increased by 6.55% to $47.7 million in 2023, then grew by 27.32% to $60.8 million in 2024, then increased by 5.23% to $64.0 million in 2025.
  • Its Operating Expenses stands at $64.0 million for Q3 2025, versus $61.5 million for Q2 2025 and $59.0 million for Q1 2025.